United Therapeutics Corp reports results for the quarter ended in December - Earnings Summary

United Therapeutics

21/02/2024 14:31

* United Therapeutics Corp  UTHR.OQ  reported quarterly
adjusted
earnings of $4.36​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of $2.67.  The mean expectation of
fourteen analysts for the quarter was for earnings of $4.19 per
share. Wall Street expected results to range from $2.97 
to $5.40 per share.
    * Revenue rose 25.1% to $614.70 million from a year ago;
analysts
expected $575.87 million. 
    * United Therapeutics Corp's reported EPS for the quarter
was
$4.36​.
    * The company reported quarterly net income of $217.1
million.
    * United Therapeutics Corp shares had fallen by 2.6% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 0.5%
in the last three months.​ 
    * In the last 30 days, two analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for United
Therapeutics Corp is $307.04 
This summary was machine generated from LSEG data February 21 at
02:30 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      4.19           4.36           Beat
 Sep. 30 2023      5.04           5.38           Beat
 Jun. 30 2023      4.51           5.24           Beat
 Mar. 31 2023      4.52           4.86           Beat